Macular Chats

Macular Chats


Geographic Atrophy: A Possible New Treatment (October 2021)

November 08, 2021

he event featured experts including Moshe Vardi, Vice President and Global Medicine Team Lead at Alexion Pharmaceuticals, and Aleksandar Skuban, MD, Executive Medical Director for Neurology and Ophthalmology Clinical Development and Translational Sciences at Alexion Pharmaceuticals, Inc. Dr. Vardi explained the role of the immune system as it relates to GMD, or geographical atrophy. Dr. Skuban talked about studies being done to determine efficacy of new treatments, including danicopan, for GMD.